Press Releases

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
DateSubject
12/23/2015 Cerus Announces Rhode Island Blood Center Enters into Agreement for the Use of INTERCEPT Platelets and Plasma
12/10/2015 Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
12/09/2015 Cerus Announces Agência Nacional de Vigilância Sanitária Approval of the INTERCEPT Blood System for Platelets and Plasma in Brazil
12/08/2015 First Patient Enrolled in Cerus’ Phase IV PIPER Study
12/07/2015 Cerus and Shepeard Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
12/04/2015 Cerus Announces Mississippi Valley Regional Blood Center Enters Into Agreement for the Use of INTERCEPT Platelets and Plasma
12/02/2015 Cerus Announces Collaboration Agreement With Haemonetics for the Use of Acrodose Platelet Kits With the INTERCEPT Blood System for Platelets
12/01/2015 Cerus and The Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
11/05/2015 Cerus Corporation Reports Third Quarter 2015 Results
11/05/2015 Cerus and OneBlood Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
11/03/2015 Cerus to Present at the Stephens 2015 Fall Investment Conference on November 10, 2015
11/02/2015 Cerus Corporation Announces CMS Issuance of Permanent P-Codes for Outpatient Hospital Billing of Pathogen-Reduced Platelets and Plasma
10/26/2015 Cerus to Release Third Quarter 2015 Results on November 5, 2015
10/21/2015 Cerus Corporation Announces New Agreement With Fresenius Kabi for the Production of INTERCEPT Blood System Kits
10/06/2015 Cerus and the Community Blood Center of the Carolinas Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
09/10/2015 Cerus to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 17, 2015
09/02/2015 Cerus to Present at the Baird 2015 Healthcare Conference on September 9, 2015
08/06/2015 Cerus Corporation Reports Second Quarter 2015 Results
08/04/2015 Cerus to Present at the 2015 Wedbush PacGrow Healthcare Conference on August 11, 2015
07/21/2015 Cerus and Unyts Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
07/13/2015 Cerus and Bonfils Blood Center Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
07/06/2015 Cerus to Release Second Quarter 2015 Results on August 6, 2015
07/01/2015 Cerus to Present at Cantor Fitzgerald’s Inaugural Healthcare Conference on July 8, 2015
06/29/2015 First INTERCEPT Pathogen Reduced Platelet Units Produced in the Continental US
06/08/2015 Richard J. Benjamin, MD PhD Appointed as Cerus Corporation’s New Chief Medical Officer
05/05/2015 Cerus Corporation Reports First Quarter 2015 Results
04/27/2015 Cerus to Present at AABB Symposium on Pathogen-Reduced Components
04/22/2015 Cerus to Release First Quarter 2015 Results on May 5, 2015
03/16/2015 First Patient Enrolled in Cerus' TRUE Study With the American Red Cross to Address Chikungunya and Dengue Blood Safety Risks With Pathogen Reduced Platelets
02/27/2015 Cerus Signs INTERCEPT Platelet Agreement With Sweden’s Largest Blood Product Supplier
02/26/2015 Cerus Corporation Reports Fourth Quarter and Year-End 2014 Results
02/24/2015 Cerus to Present at the Cowen and Company 35th Annual Health Care Conference on March 3, 2015
02/13/2015 Cerus to Release Fourth Quarter 2014 Results on February 26, 2015
02/05/2015 Cerus and SunCoast Blood Bank Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
02/04/2015 Cerus and Blood Bank of Delmarva Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
01/07/2015 Cerus Prices $70.0 Million Public Offering of Common Stock
01/05/2015 Cerus Announces Proposed Public Offering of Common Stock
01/05/2015 Cerus Reports EU Phase 3 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint

  • Global Headquarters

  • 2550 Stanwell Drive
    Concord, CA US 94520
    +1 925.288.6000

  • European Headquarters

  • Stationsstraat 79-D
    3811 MH Amersfoort, Netherlands
    +31 (0) 33 49 60 600

Email Alerts

Alerts are emailed to you when certain new company information is posted to this site.
> Sign up now!

The INTERCEPT Blood System is not approved for sale in certain countries.
  • Copyright @ 2017 Cerus Corporation. INTERCEPT, INTERCEPT Blood System and Cerus are trademarks of Cerus Corporation. InterSol and Amicus are trademarks of Fenwal, Inc.
  • Privacy
  • Legal
  • Site Map
Powered By Q4 Inc. 5.4.1.6